SERUM LEVELS OF INTERFERON-GAMMA, CYTOTOXIC FACTOR AND SOLUBLE INTERLEUKIN-2 RECEPTOR IN CHILDHOOD HEMOPHAGOCYTIC SYNDROMES

被引:61
|
作者
IMASHUKU, S
IKUSHIMA, S
ESUMI, N
TODO, S
SAITO, M
机构
[1] Division of Pediatrics, Children's Research Hospital, and Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto
[2] Applied Research Laboratory of Chugai Pharmaceutical Co. Ltd., Tokyo
关键词
INTERFERON-GAMMA; CYTOTOXIC FACTOR; SOLUBLE INTERLEUKIN-2 RECEPTOR; MALIGNANT HISTIOCYTOSIS; VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME;
D O I
10.3109/10428199109107916
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Serum levels of interferon (IFN)-gamma, cytotoxic factor (CF) and soluble interleukin-2 receptor (sIL2R) were assayed in relation to hyperferritinemia in eleven cases of malignant histiocytosis (MH), seven of virus-associated hemophagocytic syndrome (VAHS) and one of familial erythrophagocytic lymphohistiocytosis (FEL). IFN-gamma was markedly elevated (>10,000 U/ml) in 5 MH cases and only in one case of VAHS. CF was significantly elevated (> 150 U/ml) in 5 MH and 4 VAHS/FEL patients. sIL2R were remarkably elevated (> 10,000 U/ml) in 5 MH and 4 VAHS patients. In individual cases, the patterns of these parameters were quite different, suggesting the existence of a variable pathophysiology in cases with hemophagocytic syndromes. In terms of the patients' outcome, high IFN-gamma or sIL2R levels were associated with a poor prognosis while high CF appeared to be associated with a better prognosis. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 50 条
  • [1] IMMUNE ACTIVATION IN MYASTHENIA-GRAVIS - SOLUBLE INTERLEUKIN-2 RECEPTOR, INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA LEVELS IN PATIENTS SERUM
    CONFALONIERI, P
    ANTOZZI, C
    CORNELIO, F
    SIMONCINI, O
    MANTEGAZZA, R
    JOURNAL OF NEUROIMMUNOLOGY, 1993, 48 (01) : 33 - 36
  • [2] Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review
    Lin, Molly
    Park, Sujin
    Hayden, Anna
    Giustini, Dean
    Trinkaus, Martina
    Pudek, Morris
    Mattman, Andre
    Schneider, Marion
    Chen, Luke Y. C.
    ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1241 - 1251
  • [3] ABNORMALITIES IN SERUM CONCENTRATIONS OF INTERLEUKIN-2, INTERFERON-ALPHA AND INTERFERON-GAMMA IN SCHIZOPHRENIA NOT DETECTED
    GATTAZ, WF
    DALGALARRONDO, P
    SCHRODER, HC
    SCHIZOPHRENIA RESEARCH, 1992, 6 (03) : 237 - 241
  • [4] INTERLEUKIN-2 AND INTERFERON-GAMMA PRODUCTION IN FOLLICULAR LYMPHOMAS
    PEUCHMAUR, M
    EMILIE, D
    CREVON, MC
    BROUSSE, N
    GAULARD, P
    DAGAY, MF
    GALANAUD, P
    SOLALCELIGNY, P
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 95 (01) : 55 - 62
  • [5] Influence of interleukin-2 and interferon-gamma in murine schistosomiasis
    El Ridi, R
    Salem, R
    Wagih, A
    Mahana, N
    El Demellawy, M
    Tallima, H
    CYTOKINE, 2006, 33 (05) : 281 - 288
  • [6] Interleukin-10, interferon gamma, Interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis
    Lu, Y
    Hylander, B
    Brauner, A
    PERITONEAL DIALYSIS INTERNATIONAL, 1996, 16 (06): : 607 - 612
  • [7] Combination therapy with interferon-gamma and interleukin-2 for the treatment of metastatic melanoma
    Kim, CJ
    Taubenberger, JK
    Simonis, TB
    White, DE
    Rosenberg, SA
    Marincola, FM
    JOURNAL OF IMMUNOTHERAPY, 1996, 19 (01) : 50 - 58
  • [8] Autoimmune hepatitis association with single nucleotide polymorphism of interleukin-2, but not interferon-gamma
    Yousefi, Azizollah
    Mahmoudi, Elham
    Noveiry, Behnoud Baradaran
    Bidoki, Alireza Zare
    Sadr, Maryam
    Motamed, Farzaneh
    Najafi, Mehri
    Farahmand, Fatemeh
    Khodadad, Ahmad
    Fallahi, Gholam Hossein
    Rezaei, Nima
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (02) : 134 - 138
  • [9] INTERLEUKIN-2 IN ASSOCIATION WITH INCREASING DOSES OF INTERFERON-GAMMA IN PATIENTS WITH ADVANCED CANCER
    VIENS, P
    BLAISE, D
    STOPPA, AM
    BRANDELY, M
    BAUME, D
    OLIVE, D
    RESBEUT, M
    DELPERO, JR
    LOPEZ, M
    AUBERT, C
    AYME, Y
    HANS, D
    BRESSAC, C
    FAVRE, R
    MARANINCHI, D
    JOURNAL OF IMMUNOTHERAPY, 1992, 11 (03): : 218 - 224
  • [10] INTERLEUKIN-4, SOLUBLE CD23 AND INTERFERON-GAMMA LEVELS IN SERUM DURING THE FIRST 18 MONTHS OF LIFE
    BJORKSTEN, B
    BORRES, MP
    EINARSSON, R
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 34 - 36